CID16020046
Product Specifications
Background
CID16020046 is a selective GPR55 antagonist.1 In HEK293 cells expressing GPR55, the compound behaves as an antagonist on lysophosphatidylinositol (LPI) -mediated Ca2+ release but was inactive on cells expressing CB1 and CB2. It blocks LPI-induced migration of colon cancer cells.2 It displays protective effects against oxidized LDL-induced inflammation3, mitigates advanced glycation end products-induced chondrocyte activation4, and displays anti-inflammatory effects in various cells5,6. A useful tool for studying the role of GPR55 in cellular physiology.
Conjugation
Unconjugated
Buffer
White to off-white solid
Storage Conditions
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
470230-01 100 µg
FGF2, Recombinant, Human, aa143-288 (Fibroblast Growth Factor 2, BFGF, FGFB, HBGF-2)
Sign In for Pricing
View Details 470230-02 500 µg
FGF2, Recombinant, Human, aa143-288 (Fibroblast Growth Factor 2, BFGF, FGFB, HBGF-2)
Sign In for Pricing
View Details